International Journal of Cancer, 101 (1), 7-10
Lose 14-15% of your body weight* *In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
Plos One 7 , e37615 (2012)
Domestic Note: USA MADE 2-7 days delivery International 5-20 days delivery for: Anti-inflammatory
Patients are typically responsible for any deductibles, copays, or additional services not covered by insurance
Dr Laura Geige Medical Director and Senior Aesthetics Practitioner at Its Me & You Clinic, with a professional background in dentistry, medical aesthetics and cosmetic dermatology